價格 | ¥13800 | ¥17500 | ¥10600 |
包裝 | 50mg | 100mg | 25mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:化合物 Izuforant | 英文名稱:Izuforant |
CAS:1429374-83-3 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號: T61011 |
Name | Izuforant |
Description | Izuforant (JW1601) (Compound 24) has potent anti-inflammatory and anti-pruritic activities. Izuforant has a binding affinity for human serotonin 3 receptor (h5-HT3R) with an IC50 value of 9.1 μM. Izuforant is also an orally active antagonist of histamine H4 receptor (H4R) with an IC50 value of 36 nM against human H4R [1] [2]. |
In vitro | Izuforant (JW1601) (Compound 24) shows metabolic stability with CL h,int values of 3.05 and 1.33 mL/min/mg in mouse and human, respectively [1]. |
In vivo | Izuforant (JW1601) (50 mg/kg; p.o.; once) decreases histamine-and substance P-induced itching in mice [1]. Izuforant (100 mg/kg; p.o.; twice a day for 3 weeks) inhibits oxazolone-induced atopic dermatitis in mice [1]. Animal Model: Female, ICR mice (8 weeks old) [1] Dosage: 50 mg/kg Administration: Oral administration, once Result: Decreased histamine-and substance P-induced itching. Animal Model: Female, Balb/c mice (6 weeks old, 20±3 g) [1] Dosage: 100 mg/kg Administration: Oral administration, twice a day for 3 weeks Result: Inhibited oxazolone-induced atopic dermatitis (51.2% inhibition). Animal Model: ICR mouse (20~30 g) and SD rat (200~300 g) [1] Dosage: 50 mg/kg for mice and 10 mg/kg for rats Administration: Oral administration (Pharmacokinetic Analysis) Result: Pharmacokinetics parameter of Izuforant (Compound 24) [1] Compound Mouse Rat t 1/2 (h) C max (μg/mL) AUC inf (μg hr/mL) t 1/2 (h) C max (μg/mL) AUC inf (μg hr/mL) Izuforant 0.96 18.87 32.17 1.30 2.42 4.51 |
Storage | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
青島愷潤生物醫(yī)藥科技有限公司
|
2025-02-07 | |
詢價 |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 | |
詢價 |
VIP5年
|
山東沃德森生物科技有限公司
|
2025-02-06 |